Identification of potent biparatopic antibodies targeting FGFR2 fusion-driven cholangiocarcinoma.

Saved in:
Bibliographic Details
Title: Identification of potent biparatopic antibodies targeting FGFR2 fusion-driven cholangiocarcinoma.
Authors: Chaturantabut S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Faculty of Pharmacy, Silpakorn University, Nakhon Pathom, Thailand., Oliver S; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Frederick DT; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Kim JJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Robinson FP; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Sinopoli A; Ridgeline Discovery GmbH, Basel, Switzerland., Song TY; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., He Y; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Chang YC; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Rodriguez DJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Chang L; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Kesar D; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Ching M; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Dzvurumi R; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Atari A; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Tseng YY; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA., Bardeesy N; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.; Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA., Sellers WR; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Source: The Journal of clinical investigation [J Clin Invest] 2025 Feb 27; Vol. 135 (8). Date of Electronic Publication: 2025 Feb 27 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: eCollection Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1558-8238
DOI:10.1172/JCI182417